Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.TA)

TEVA.TA on Tel Aviv Stock Exchange

2,929.00ILa
17 Jun 2019
Change (% chg)

-- (--)
Prev Close
2,929.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
989,017
52-wk High
9,475.00
52-wk Low
2,890.00

About

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops, manufactures and sells generic... (more)

Overall

Beta: 1.24
Market Cap(Mil.): ₪65,841.12
Shares Outstanding(Mil.): 1,014.36
Dividend: 30.51
Yield (%): 6.31

Financials

  TEVA.TA Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -21.22 -- --
ROI: -10.61 14.23 13.82
ROE: -24.14 15.46 15.24

Oklahoma judge mulls governor's concerns over Teva opioid settlement

An Oklahoma judge on Monday asked the state's attorney general to respond to arguments by the state's governor and legislative leaders that Teva Pharmaceutical Industries Ltd's $85 million opioid litigation settlement violates a new law they say requires the funds to be deposited in the state's treasury.

Jun 17 2019

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

BOSTON/JERUSALEM Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic. | Video

May 27 2019

UPDATE 2-Teva Pharm to pay Oklahoma $85 mln to settle opioid claims

BOSTON/JERUSALEM, May 26 Teva Pharmaceutical Industries Ltd said on Sunday it had agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped fuel the U.S. opioid epidemic.

May 26 2019

Oklahoma reaches $85 mln settlement with Teva Pharmaceuticals ahead of trial

May 26 Oklahoma has reached a $85 million settlement agreement with Israeli-based Teva Pharmaceutical Industries Ltd ahead of the start of a trial in a multibillion-dollar lawsuit over the opioid epidemic, the state's attorney general said on Sunday.

May 26 2019

J&J, Teva lose last-minute bid to escape Oklahoma opioid lawsuit

An Oklahoma judge on Monday cleared the way for Johnson & Johnson and Teva Pharmaceutical Industries Ltd to face trial at the end of May in a lawsuit by the state's attorney general accusing the drugmakers of helping fuel the opioid epidemic.

May 13 2019

Teva Pharm CFO says company did not conspire to fix prices

JERUSALEM Teva Pharmaceutical Industries' chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 U.S. states.

May 12 2019

Teva Pharm CFO says company did not conspire to fix prices

JERUSALEM, May 12 Teva Pharmaceutical Industries' chief financial officer on Sunday reiterated that the company has done nothing wrong in the wake of a price-fixing lawsuit filed by 44 U.S. states.

May 12 2019

U.S. states accuse Teva, other drugmakers, of price-fixing: lawsuit

WASHINGTON U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices - sometimes by more than 1,000% - and stifle competition for generic drugs, state prosecutors said on Saturday.

May 11 2019

UPDATE 2-U.S. states accuse Teva, other drugmakers, of price-fixing -lawsuit

WASHINGTON, May 11 U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices - sometimes by more than 1,000% - and stifle competition for generic drugs, state prosecutors said on Saturday.

May 11 2019

U.S. states sue Teva, 19 other drug companies in price-fixing complaint

WASHINGTON, May 11 Forty-four U.S. states have filed a lawsuit accusing 20 drug companies including Teva Pharmaceuticals USA Inc of a sweeping scheme to inflate drug prices and stifle competition for more than 100 generic drugs, state prosecutors said on Saturday.

May 11 2019

Earnings vs. Estimates